The Role of T Cell Costimulation by CD80 in the Initiation and Maintenance of the Immune Response to Human Leukemia

References

• Weiden P. L., Flournoy N., Thomas E. D., Prentice R., Fefer A., Buckner C. D., Storb R. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New England Journal of Medicine 1979; 300: 1068–1073
   PubMed Web of Science ®Google Scholar
• Moller P., Hammerling G. J. The role of surface HLA-A, B, C molecules in tumour immunity. Cancer Surveys 1992; 13: 101–127
   PubMedGoogle Scholar
• Chen W., Peace D. J., Rovira D. K., You S. G., Cheever M. A. T-cell immunity to the joining region of p210BCR-ABL protein. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 1468–1472
   PubMed Web of Science ®Google Scholar
• Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J., Nadler L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261–3282
   PubMed Web of Science ®Google Scholar
• Martin P., Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233–1235
   PubMed Web of Science ®Google Scholar
• Symington F. W., Levine F., Braun M., Brown S. L., Erlich H. A., Torok-Storb B. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines. Journal of Immunology 1985; 135: 1026–1032
   PubMed Web of Science ®Google Scholar
• Torok-Storb B., Graf L., Shankar P. Inhibition of erythroid progenitor growth is mediated by cytotoxic lymphocytes and not by natural killer cells or IFN-gamma. Journal of Immunology 1989; 143: 1837–1842
   PubMed Web of Science ®Google Scholar
• Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349–1356
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freeman G. J., Boussiotis V. A., Rennert P., Jellis C. L., Greenfield E., Barber M., Restivo V. A. J., Ke X., Gray G. S. CTLA4 mediates antigen-specific apoptosis of human T cells. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 811–815
   PubMed Web of Science ®Google Scholar
• Harding F. A., McArthur J. G., Gross J. A., Raulet D. H., Allison J. P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607–609
   PubMed Web of Science ®Google Scholar
• Tan P., Anasetti C., Hansen J. A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J. A., Linsley P. S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. Journal of Experimental Medicine 1993; 177: 165–173
   PubMed Web of Science ®Google Scholar
• Hansen J. A., Martin P. J., Beatty P. G., Clark E. A., Ledbetter J. A. Human T lymphocyte cell surface moleculess defined by the workshop monoclonal antibodies (“T cell protocol”). Leukocyte Typing Human Keukocyte Markers Detected by Monoclonal Antibodies, A. Bernard, L. Boumsell, J. Dausset, C. Milstein, S. F. Schlossman. Springer-Verlag, New York 1984; 195–212
   Google Scholar
• Kamoun M., Martin P. J., Kadin M. E., Lum L. G., Hansen J. A. Human monocyte-histiocyte differentiation antigens identified by monoclonal antibodies. Clinical Immunology and Immunopathology 1983; 29: 181–195
   PubMedGoogle Scholar
• Croft M., Bradley L. M., Swain S. L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. Journal of Immunology 1994; 152: 2675–2685
   PubMed Web of Science ®Google Scholar
• Azuma M., Cayabyab M., Buck D., Phillips J. H., Lanier L. L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. Journal of Experimental Medicine 1992; 175: 353–360
   PubMed Web of Science ®Google Scholar
• Norton S. D., Zuckerman L., Urdahl K. B., Shefner R., Miller J., Jenkins M. K. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. Journal of Immunology 1992; 149: 1556–1561
   PubMed Web of Science ®Google Scholar
• Schultze J. L., Cardoso A. A., Freeman G. J., Seamon M. J., Daley J., Pinkus G. S., Gribben J. G., Nadler L. M. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 8200–8204
   PubMed Web of Science ®Google Scholar
• Cardoso A. A., Schultze J. L., Boussiotis V. A., Freeman G. J., Seamon M. J., Laszlo S., Billet A., Sallan S. E., Gribben J. G., Nadler L. M. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 1996; 88: 41–48
   PubMed Web of Science ®Google Scholar
• Dohring C., Angman L., Spagnoli G., Lanzavecchia A. T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. International Journal of Cancer 1994; 57: 754–759
   PubMed Web of Science ®Google Scholar
• Dubey C., Croft M., Swain S. L. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7–1 can costimulate naive CD4 T cell activation but both are required for optimum response. Journal of Immunology 1995; 155: 45–57
   PubMed Web of Science ®Google Scholar
• Green J. M., Noel P. J., Sperling A. I., Walunas T. L., Gray G. S., Bluestone J. A., Thompson C. B. Absence of B7-dependent responses in CD28- deficient mice. Immunity 1994; 1: 501–508
   PubMed Web of Science ®Google Scholar
• Springer T. A. Adhesion receptors of the immune system. [Review] [165 refs]. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Lucas P. J., Negishi I., Nakayama K., Fields L. E., Loh D. Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. Journal of Immunology 1995; 154: 5757–5768
   PubMed Web of Science ®Google Scholar
• Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995; 3: 87–98
   PubMed Web of Science ®Google Scholar
• Matulonis U. A., Dosiou C., Lamont C., Freeman G. J., Mauch P., Nadler L. M., Griffin J. D. Role of B7–1 in mediating an immune response to myeloid leukemia cells. Blood 1995; 85: 2507–2515
   PubMed Web of Science ®Google Scholar